Tecan appoints Dr. Klaus Lun to the Management Board
(Thomson Reuters ONE) -
Tecan Group AG /
Tecan appoints Dr. Klaus Lun to the Management Board
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Männedorf, Switzerland, May 23, 2013 - The Tecan Group (SIX Swiss Exchange:
TECN) announced today that Dr. Klaus Lun has been appointed Head of Corporate
Development and a member of the Management Board. He will take up his new post
at Tecan on June 4, 2013.
Tecan CEO David Martyr commented: "Our strategic goal is to evolve Tecan in the
medium term from a highly specialized instrument supplier to a provider of
complete solutions. We're also working to grow the company via non-organic means
through very carefully selected acquisitions and collaborations. Klaus Lun has
the ideal background for this position, with several years of experience in
Corporate Development as well as responsibility for an operating division in our
sector. Whilst at Leica Microsystems, I already worked successfully with Klaus
Lun on a number of takeovers and have come to know him as an extremely focused
and well-organized manager with a strategic way of thinking. We are delighted
that Klaus Lun is going to be joining our management team, strengthening us in
this strategically vital area."
Klaus Lun has extensive experience in a variety of management positions in the
life science industry. Since 2011, he worked at Molecular Devices Inc., a
company belonging to the Danaher Group. As Vice President Drug Discovery and
Bioresearch, Klaus Lun was responsible for running the Drug Discovery and
Bioresearch business. Most recently, he became Vice President Global Product
Marketing with responsibility for strategy development, positioning and
marketing for the entire product portfolio.
Klaus Lun was Director Business Development from 2007 to 2011 at Leica
Microsystems, also part of the Danaher Group, where he was responsible for
corporate mergers, takeovers and licensing. In this capacity, he managed several
takeovers by Leica Microsystems and successfully integrated the newly acquired
companies into its existing business operations. Klaus Lun was also closely
involved in a number of transactions entered into by the parent company Danaher.
From 2002 to 2007, Klaus Lun held a variety of positions at Amaxa GmbH, which is
now part of the Lonza Group, most recently as a Senior Project Manager with
responsibility, among other things, for the development and rollout onto the
market of a variety of clinical products.
Klaus Lun studied biology at the University of Tübingen and gained his doctorate
in neurobiology at the University of Heidelberg. He also has an MBA from the
University of Mannheim. Klaus Lun is 40 years old and an Italian citizen.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics and clinical diagnostics. The company
specializes in the development, production and distribution of automated
workflow solutions for laboratories in the life sciences sector. Its clients
include pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original equipment
manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM
instruments and components that are then distributed by partner companies.
Founded in Switzerland in 1980, the company has manufacturing, research and
development sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2012, Tecan generated sales of
CHF 391 million (USD 416 million; EUR 323 million). Registered shares of Tecan
Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor(at)tecan.com
www.tecan.com
Press Release (PDF):
http://hugin.info/100384/R/1703980/563356.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Tecan Group AG via Thomson Reuters ONE
[HUG#1703980]
Unternehmensinformation / Kurzprofil:
Datum: 23.05.2013 - 07:26 Uhr
Sprache: Deutsch
News-ID 262768
Anzahl Zeichen: 5038
contact information:
Town:
Männedorf
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 259 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tecan appoints Dr. Klaus Lun to the Management Board"
steht unter der journalistisch-redaktionellen Verantwortung von
Tecan Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
